Literature DB >> 15813854

Nicotinic acetylcholine receptor-mediated stimulation of endothelial cells results in the arrest of haematopoietic progenitor cells on endothelium.

Naira Serobyan1, Ingrid U Schraufstatter, Alex Strongin, Sophia K Khaldoyanidi.   

Abstract

The function of endothelial cells that contribute to the regulation of haematopoietic stem/progenitor cells (HSPC) migration from peripheral blood into bone marrow can be influenced by extrinsic factors including nicotine. Therefore, the effect of nicotine on HSPC extravasation was studied. Using a parallel laminar flow chamber, we demonstrated an increase in the number of HSPC adhering to the nicotine-exposed endothelium under conditions of physiological shear stress in vitro. Nicotine-induced adhesion of HSPC was inhibited by mecamylamine, a non-selective nicotinic acetylcholine receptor (nAchR) antagonist. The enhanced adhesive interactions of HSPC with nicotine-exposed endothelial monolayers coincided with the nicotine-induced activation of endothelial cells. Nicotine induced fast cytoskeletal reorganization and formation of filopodia in endothelial cells through interaction with the non-neuronal nAchR expressed by these cells. In addition, nicotine treatment stimulated rapid phosphorylation of Erk1/2 and p-38 in endothelial cells. Finally, nicotine inhibited the stroma derived factor-1-mediated transendothelial migration of HSPC. Decreased migration of HSPC correlated with diminished matrix metalloproteinase-9 activity secreted by bone marrow cells and decreased expression of CD44 on the surface of endothelial cells. Overall, our data suggest that exposure to nicotine causes endothelial cell dysfunction and leads to the pathological arrest of HSPC on endothelium, interfering with their proper migration process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813854     DOI: 10.1111/j.1365-2141.2005.05446.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?

Authors:  Edwin Chang; E Camilla Forsberg; Jenny Wu; Susan S Prohaska; Rich Allsopp; Irving L Weissman; John P Cooke
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

2.  Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells.

Authors:  Ingrid U Schraufstatter; Richard G DiScipio; Sophia K Khaldoyanidi
Journal:  J Stem Cells       Date:  2009

3.  The cholinergic system is involved in regulation of the development of the hematopoietic system.

Authors:  Naira Serobyan; Suchitra Jagannathan; Irina Orlovskaya; Ingrid Schraufstatter; Marina Skok; Jeanne Loring; Sophia Khaldoyanidi
Journal:  Life Sci       Date:  2007-04-29       Impact factor: 5.037

4.  Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking.

Authors:  Kelly S Schweitzer; Brian H Johnstone; Jana Garrison; Natalia I Rush; Scott Cooper; Dmitry O Traktuev; Dongni Feng; Jeremy J Adamowicz; Mary Van Demark; Amanda J Fisher; Krzysztof Kamocki; Mary Beth Brown; Robert G Presson; Hal E Broxmeyer; Keith L March; Irina Petrache
Journal:  Am J Respir Crit Care Med       Date:  2010-08-13       Impact factor: 21.405

5.  Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway.

Authors:  Florence Figeac; Maylis Dagouassat; Meriem Mahrouf-Yorgov; Sabine Le Gouvello; Céline Trébeau; Angeliqua Sayed; Jean-Baptiste Stern; Pierre Validire; Jean-Luc Dubois-Randé; Jorge Boczkowski; Isabelle Mus-Veteau; Anne-Marie Rodriguez
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway.

Authors:  Claude Sadis; Gwen Teske; Geurt Stokman; Carole Kubjak; Nike Claessen; Fabrice Moore; Patrizia Loi; Bilo Diallo; Luc Barvais; Michel Goldman; Sandrine Florquin; Alain Le Moine
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.